Flora Growth Corp. (FLGC)

CA — Healthcare Sector
Peers: ALID  BFRI  CLVR  DBGI  ENSC  IMCC  KHRNF  MDIA  MTVA  VRPX 

Automate Your Wheel Strategy on FLGC

With Tiblio's Option Bot, you can configure your own wheel strategy including FLGC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol FLGC
  • Rev/Share 2.7937
  • Book/Share 0.2496
  • PB 2.5443
  • Debt/Equity 1.1034
  • CurrentRatio 1.0498
  • ROIC -0.8162

 

  • MktCap 14331125.0
  • FreeCF/Share -0.3404
  • PFCF -2.2082
  • PE -0.9108
  • Debt/Assets 0.2344
  • DivYield 0
  • ROE -2.5526

 

  • Rating C-
  • Score 1
  • Recommendation Strong Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 3
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Flora Growth Announces Results of 2025 Annual and Special Meeting of Shareholders
FLGC
Published: June 30, 2025 by: Newsfile Corp
Sentiment: Neutral

Fort Lauderdale, Florida--(Newsfile Corp. - June 30, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") held its 2025 Annual and Special Meeting of Shareholders (the "Annual Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: Election of five directors to the board of directors of the Company (the "Board") to hold office until the Company's 2026 Annual Meeting of Shareholders or until their respective successors are elected or appointed: Broker Director For Against Abstentions Non-Votes Clifford Starke 7,329,521 1,500,756 …

Read More
image for news Flora Growth Announces Results of 2025 Annual and Special Meeting of Shareholders

About Flora Growth Corp. (FLGC)

  • IPO Date 2021-05-11
  • Website https://www.floragrowth.com
  • Industry Drug Manufacturers - Specialty & Generic
  • CEO Clifford A. Starke
  • Employees 64
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.